Outcome and survival with nonsurgical management of renal cell carcinoma


A.D. Baird, Department of Urology, Royal Liverpool University Hospital, Prescot Street, Liverpool L7 8XP, UK.
e-mail: andy.baird@breathemail.net



To document long-term survival in patients with renal cell carcinoma (RCC) in whom the primary tumour was left in situ and treatment limited to palliative and symptomatic measures.


All patients with a diagnosis of RCC from January 1994 to January 1999 and in whom the primary tumour was left in situ were identified from hospital records (nine women and 16 men, mean age 69 years). The tumour stage was T1–T4.


The mean survival overall was 19.3 months; patients with locally advanced disease, i.e. stage ≥ T3a, had a mean survival of 16.9 months.


There is renewed interest in the management of advanced RCC, with data supporting cytoreductive nephrectomy with systemic biological therapy. These results confirm that such patients with or without metastatic disease can survive for a considerable period with no aggressive surgical or systemic measures, and such intervention may offer no significant advantage in outcome and survival over supportive treatment alone.